Literature DB >> 15906171

Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.

Haranath K Vaddi1, Mohamed O Hamad, Jianhong Chen, Stan L Banks, Peter A Crooks, Audra L Stinchcomb.   

Abstract

PURPOSE: Physicochemical characterization and in vitro human skin diffusion studies of branched-chain ester and carbonate prodrugs of naltrexone (NTX) were compared and contrasted with straight-chain ester and carbonate NTX prodrugs.
METHODS: Human skin permeation rates, thermal parameters, solubilities in mineral oil and buffer, and stabilities in buffer and plasma were determined. Partition coefficients between stratum corneum and vehicle were determined for straight- and branched-chain esters with the same number of carbon atoms.
RESULTS: Branched prodrugs had lower melting points, lower buffer solubilities, and higher mineral oil solubilities than NTX. The transdermal flux values from all of these branched prodrugs were significantly lower than flux values from the straight-chain ester and the methyl carbonate prodrugs. Straight-chain prodrugs had higher partition coefficient values and higher calculated thermodynamic activities than their branched-chain counterparts. The prodrug hydrolysis to NTX in buffer and plasma was slower for prodrugs with increased branching.
CONCLUSIONS: Branched-chain prodrugs with bulky moieties had smaller stratum corneum-vehicle partition coefficients and lower thermodynamic activities that resulted in smaller transdermal flux values than straight-chain prodrugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906171     DOI: 10.1007/s11095-005-2592-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.

Authors:  P Vlieghe; F Bihel; T Clerc; C Pannecouque; M Witvrouw; E De Clercq; J P Salles; J C Chermann; J L Kraus
Journal:  J Med Chem       Date:  2001-03-01       Impact factor: 7.446

2.  Metabolism of fluroxypyr, fluroxypyr methyl ester, and the herbicide fluroxypyr methylheptyl ester. I: during percutaneous absorption through fresh rat and human skin in vitro.

Authors:  P G Hewitt; J Perkins; S A Hotchkiss
Journal:  Drug Metab Dispos       Date:  2000-07       Impact factor: 3.922

3.  PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM.

Authors:  A M KLIGMAN; E CHRISTOPHERS
Journal:  Arch Dermatol       Date:  1963-12

4.  Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.

Authors:  Audra L Stinchcomb; Peter W Swaan; Opinya Ekabo; Kathleen K Harris; Jennifer Browe; Dana C Hammell; Todd A Cooperman; Michael Pearsall
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

5.  Naltrexone and alcohol dependence. Role of subject compliance.

Authors:  J R Volpicelli; K C Rhines; J S Rhines; L A Volpicelli; A I Alterman; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1997-08

6.  Prediction of transdermal flux of prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine with a series/parallel model.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  2000-11       Impact factor: 3.534

7.  Physicochemical evaluation, in vitro human skin diffusion, and concurrent biotransformation of 3-O-alkyl carbonate prodrugs of naltrexone.

Authors:  Omathanu Pillai; Mohamed O Hamad; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach.

Authors:  M A Hussain; C A Koval; M J Myers; E G Shami; E Shefter
Journal:  J Pharm Sci       Date:  1987-05       Impact factor: 3.534

9.  Naltrexone in the treatment of alcohol dependence.

Authors:  J R Volpicelli; A I Alterman; M Hayashida; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1992-11

10.  Cyclization-activated prodrugs: N-(substituted 2-hydroxyphenyl and 2-hydroxypropyl)carbamates based on ring-opened derivatives of active benzoxazolones and oxazolidinones as mutual prodrugs of acetaminophen.

Authors:  A Vigroux; M Bergon; C Zedde
Journal:  J Med Chem       Date:  1995-09-29       Impact factor: 7.446

View more
  9 in total

1.  Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.

Authors:  Thirupathi Reddy Yerramreddy; Mikolaj Milewski; Narsimha Reddy Penthala; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

2.  Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.

Authors:  Mikolaj Milewski; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2010-06-25       Impact factor: 4.200

3.  Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.

Authors:  Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

4.  Synthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal delivery.

Authors:  Joshua A Eldridge; Mikolaj Milewski; Audra L Stinchcomb; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2014-10-02       Impact factor: 2.823

5.  In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.

Authors:  Satyanarayana Valiveti; Kalpana S Paudel; Dana C Hammell; Mohamed O Hamad; Jianhong Chen; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

6.  Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.

Authors:  Stan L Banks; Raghotham R Pinninti; Harvinder S Gill; Peter A Crooks; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2008-05-01       Impact factor: 4.200

7.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans.

Authors:  Daniel P Wermeling; Stan L Banks; David A Hudson; Harvinder S Gill; Jyoti Gupta; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

Review 8.  Prodrug strategies for enhancing the percutaneous absorption of drugs.

Authors:  David D N'Da
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

9.  Preparation of mixed trialkyl alkylcarbonate derivatives of etidronic acid via an unusual route.

Authors:  Petri A Turhanen; Janne Weisell; Jouko J Vepsäläinen
Journal:  Beilstein J Org Chem       Date:  2012-11-20       Impact factor: 2.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.